肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布。结果表明（1）HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40％（55／136）和82％（112／136）。HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;（2）HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81％（133／164）及86％（141／164）。C33c抗原定位于癌细胞及肝细胞的浆内;核心抗原毁定位于癌细胞核中,又可定位于胞浆中。C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细胞在癌组织以弥漫核阳性常见,在癌旁肝组织以胸浆阳性为主;（3）HBxAg在肝细胞肝 癌中的检出率为75％（123／164）,C33c和HBxAg二者同时阳性占63％（103／164）。HCV感染在我国肝细胞肝癌中比较普遍,HCV和HBV重叠感染占相当比例,可能在肝细胞肝癌的发生中起着重要作用。     

肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细     

Raji细胞培养中HSV持续感染模型的建立及免疫因素(TNF IFNs)对它的影响

本文观察HSV持续感染Raji细胞培养物150天。发现整个感染过程似呵分为两个阶段:急性期(前30天)和稳定期(30天以后)。在急性期上清液中HSV滴度达10~(6.2)TCID_(50)/ml.病毒抗原阳性细胞达21％,死细胞达42％;在稳定期病毒和细胞处于相对平衡状态,上清液中IISV滴度在10~(3.5-4.2)TCID_(50)/ml,病毒抗原阳性细胞约占5—10％,感染细胞与对照细胞在生长特性上无明显差异。用rIFNs、rlL-2和TNF处理稳定期的细胞培养物,发现TNF和rlFNa能明显抑制HSV的复制,rIENy作用较弱,去除上述因子5天后又恢复到处理前水平。rlL-2无明显作用。用HSV抗体处理上述细胞培养物上清液中病毒和病毒抗原阳性细胞都消失,且在去除抗体后连续观察50天仍未出现。本实验为体外研究HSV持续感染提供了一个有用的模型。     

丙型肝炎病毒核心基因置换对病毒复制和感染影响的初步研究

本文旨在探讨丙型肝炎病毒(HCV)核心(core)蛋白在病毒复制和感染中的作用,采取基因置换的方法,用HCV1b型J4株的核心基因平行置换2a型J6JFH1株的核心区,构建了FL-J6JFH/J4core嵌合复制子。体外制备RNA转录体,以脂质体介导转染Huh7.5.1肝癌细胞。转染后第5天,用荧光定量聚合酶链反应(FQ-PCR)检测细胞内HCVRNA水平。第8天,以丙型肝炎患者血清为一抗,免疫荧光法(IFA)检测转染细胞内HCV蛋白表达。同时收集转染后第8天的细胞上清液,感染naveHuh7.5.1肝癌细胞,72h后IFA检测HCV蛋白表达。结果显示,FL-J6JFH/J4core转染组第5天细胞内RNA水平与野生型FL-J6JFH1接近,无显著差异(n=4,P0.05)。免疫荧光检测显示,FL-J6JFH/J4core转染细胞后第8天及其上清液感染的naveHuh7.5.1细胞的HCV阳性细胞数都低于野生型。本研究结果初步表明,HCV各株间核心基因的替换会影响HCV的蛋白翻译和感染性病毒颗粒的产生与释放。     

黄芪对镉致大鼠睾丸支持细胞超微结构及波形蛋白、E-钙粘蛋白表达改变的保护作用

目的 探讨黄芪对镉致大鼠睾丸支持细胞损伤的保护作用.方法 21只成年雄性SD大鼠随机分成镉组(0.1％氯化镉腹腔内注射,1mg/Kg体重/天,5天/周,处理后1、2、3、4周取材)、镉加黄芪组(注射氯化镉的同时注射黄芪,10g/Kg体重/天,5天/周,处理后2、4周取材)和对照组(腹腔内注射等量生理盐水).睾丸取材作光镜、免疫组织化学染色和图像分析及超微结构观察.结果 光镜H.E染色对照组支持细胞核不规则,染色浅,核仁明显,镉处理后胞浆内有空泡形成,镉加黄芪组支持细胞未见明显改变.对照组波形蛋白阳性产物在支持细胞靠近基室腔的胞浆中表达,E-钙粘蛋白阳性产物则主要定位于生精上皮近腔室的支持细胞和部分生精细胞胞浆中.镉处理后支持细胞胞浆中波形蛋白和E-钙粘蛋白阳性产物表达的平均光密度值均明显降低(P＜0.05),镉加黄芪组阳性产物表达虽较对照组减弱但明显高于相应镉组(P＜0.05).镉处理组支持细胞胞质特化区和紧密连接破坏,镉加黄芪组支持细胞超微病变较相应镉组为轻.结论 镉降低大鼠睾丸支持细胞波形蛋白和E-钙粘蛋白的表达并造成支持细胞的超微结构损伤,黄芪具有较好的保护效果.     

免疫酶技术及其对副流感病毒(仙台株)抗原的定位观察

采用辣根过氧化物酶标记抗体的方法,对副流感病毒(仙台株)抗原在组织细胞内的繁殖部位进行了光学显微镜和电子显微镜的观察。在受病毒感染的小鼠肺切片上,多数细支气管上皮细胞及部分肺泡细胞胞浆内呈明显阳性;在体外实验中,受感染的单层人胚肾细胞的胞桨膜、胞浆膜表面的病毒颗粒以及部分胞浆均可见阳性反应。此外,本文还对结果的特异性,酶标记技术中抗原的固定,酶与免疫球蛋白的结合以及酶标记抗体进入组织细胞等方法学问题进行了一些探讨。     

蓝舌病毒HbC3株对小鼠乳腺癌MA-782细胞的感染特性

体外研究蓝舌病毒湖北株3(BTV-HbC3)对鼠乳腺癌细胞MA782的感染性并探讨BTV-HbC3靶向性溶癌的机制。观察MA782细胞感染BTV-HbC3的病变效应(CPE);MTT法研究病毒致细胞病变率的特征;透射电镜观察感染病毒后细胞超微结构的变化;免疫组化研究病毒蛋白在细胞内的表达特点;凋亡染色(TUNEL法)观察病毒诱导细胞凋亡的情况;流式细胞仪测定病毒对MA782细胞周期的影响。结果证明BTV-HbC3感染MA782细胞后有明显的细胞病变效应;病毒蛋白主要表达在细胞的胞膜及胞浆内;凋亡染色发现大量的凋亡细胞;流式细胞仪可见明显的亚二倍体峰。故认为BTV-HbC3在体外能有效的感染MA782细胞,并能诱导MA782细胞凋亡。     

蓝舌病毒HbC3株对小鼠乳腺癌MA-782细胞的感染特性

体外研究蓝舌病毒湖北株3(BTV-HbC3)对鼠乳腺癌细胞MA782的感染性并探讨BTV-HbC3靶向性溶癌的机制.观察MA782细胞感染BTV-HbC3的病变效应(CPE);MTT法研究病毒致细胞病变率的特征;透射电镜观察感染病毒后细胞超微结构的变化;免疫组化研究病毒蛋白在细胞内的表达特点;凋亡染色(TUNEL法)观察病毒诱导细胞凋亡的情况;流式细胞仪测定病毒对MA782细胞周期的影响.结果证明BTV-HbC3感染MA782细胞后有明显的细胞病变效应;病毒蛋白主要表达在细胞的胞膜及胞浆内;凋亡染色发现大量的凋亡细胞;流式细胞仪可见明显的亚二倍体峰.故认为BTV-HbC3在体外能有效的感染MA782细胞,并能诱导MA782细胞凋亡.     

胸腺树突状细胞对胸腺细胞凋亡的促进作用

小鼠胸腺细胞在体外培养一定时间后自发出现凋亡,在与小鼠胸腺树突状细胞(MTSC4)共育后,其凋亡过程可被明显加速;与此相反,小鼠胸腺上皮细胞(MTECI)有抑制凋亡的作用.与MTSC4共育后的胸腺细胞中不仅CD4⁺CD8⁺双阳性细胞明显减小,而且CD4⁺CD8⁺单阳性细胞也减少.提示胸腺基质细胞可通过其对细胞凋亡的促进作用参与胸腺内的阴性选择,并提示阴性选择可能在胸腺髓质区仍在进行.     

人脐静脉内皮细胞表面血型ABO抗原、HLA抗原、CD抗原表达特性

用人脐静脉内皮细胞体外培养方法和ABC免疫酶标技术,检测细胞表面抗原分布。结果表明:原代培养的10例人脐静脉内皮细胞,5例红细胞A抗原阳性;2例红细胞B抗原阳性;1例红细胞A、B抗原均阳性;2例红细胞A、B抗原均阴性。其中5例A型脐带血肉皮细胞分别检测HLA-ABC、HLA-DR、CD_4、CD_8抗原均阳性,自动图像分析证实有上述抗原分子表达。此外,本文研究证明,体外培养两周的内皮细胞具有表达抗原的功能。实验结果提示:体外短期培养的内皮细胞能保持其一般生物学和免疫学特征,其表达的抗原分子可能参与和调节着机体的免疫功能。     

SABC法和胶体金标免疫电镜观察体外感染细胞中HCV—NS5的表达

寻找敏感的丙型肝炎病毒 (ＨＣＶ)体外培养系统 ,对于研究ＨＣＶ的病毒体特征、致病机理、抗病毒治疗和疫苗研制等方面有着重要的意义。我们曾在体外感染的人Ｔ淋巴细胞中发现ＨＣＶ的正、负链[1] ,随后对于ＨＣＶ在体外感染细胞中的抗原表达情况又做了进一步研究 ,现报道结果如下。1　材料和方法1.1　ＨＣＶＲＮＡ阳性接种物选择ＨＣＶＲＮＡ水平为 2× 10 4 拷贝 /ｍＬ(荧光定量法。试剂盒由美国Ｂｉｏｔｒｏｎｉｃｓ公司提供 )的血清 ,该血清检查甲、乙、丁、戊型肝炎标志为阴性 ,以此作为接种物 ,同时 ,选用正常人的血清作阴性对照。1.2…     

SABC法和胶体金标免疫电镜观察 体外感染细胞中HCV-NS5的表达

To study the expression of HCV non-structure 5 antigen in vitro, a human HepG2 cell line was incubated with a HCV RNA positive serum. The S ABC i mmunological techniques and gold-labeled colloid electron microscopy method wer e employed to examine for the viral proteins in those cells. The HCV non-struct ure 5 antigen was first detected in the HepG2 cells at 72 hours post incubation. The antigen was continuously observed in the cytoplasm or on the membrane as we ll on the cell wall of the HepG2 cells even after 1, 2, 3 and 4 weeks post incub ation. The observation of HCV non-structure 5 antigen continuously expressed in the HepG2 cells strongly indicates that the cells may have been infected by HCV virus and the virus may have replicated in the cells. Therefore, the HepG2 cell line may be served as a potential host for establishment of HCV infection and p ropagation in vitro.     

肝癌细胞系（HepG2）感染HCV RNA的研究

为建立丙型肝炎病毒（HCV）体外感染和细胞培养系统,用定量的HCV RNA阳性血清感染人肝癌细胞系（HepG2细胞系）,应用地高辛标记HCV RNA探针原位杂交技术和RT－PCR方法对感染后的细胞和上清液听 HCV RNA进行了检测。在感染后的第一代至第七代的细胞中出现特异性杂交阳性信号,第一代、第二代和第六代检测出HCV RNA正链,并在感染后第一、二代检测出HCV RNA负链。显示HCV不仅能在体外感染HepG2细胞系,而且在基因的复制,证明HepG2细胞能作为HCV的体外细胞培育系。     

HCV infective virions can be carried by human platelets

It has been previously demonstrated that platelets (PLTs) can bind and transport HIV-1 infectious virions. Hepatitis C virus (HCV)-HIV-1 co-infection occurs frequently among users of illicit intravenous drugs, thereby increasing the severity of HIV disease and the evolution towards chronic active hepatitis and hepatocellular carcinoma of HCV-related hepatitis. In the present study we investigated whether or not PLTs can carry HCV, and studied the binding mechanisms. Purified PLTs, obtained from healthy donors, HCV negative and HIV negative, were adsorbed with HCV-containing serum and then employed to infect a THP-1 monocytoid cell line. Replication of HCV was observed as shown by positivity for the E2 antigen within THP-1 cells, by indirect immunofluorescence; moreover, HCV-RNA was detected in supernatants of THP-1 cells at day 7 post-incubation with HCV-adsorbed PLTs. The binding of HCV to PLTs seems to involve fibronectin (FN), as already shown in the case of HIV-1. Indeed, treatment with RGD (Gly-Arg-Gly-Asp-Ser), the key oligopeptide of FN binding, inhibits the ability of HCV to be carried by PLTs in infective forms; the same phenomenon occurs with Mabs to FN. Moreover the infection of THP-1 cells seems to increase FN surface expression, as demonstrated by immunofluorescence tests.     

HCV immunology--death and the maiden T cell

Cellular immune responses play an important role in the control of hepatitis C virus (HCV), although in the majority of cases they ultimately fail. We examine the mechanisms by which virus-specific T cells may interact with a cell that is infected with HCV and how this interaction may explain the success and failure of the immune response. As an infected cell presenting foreign antigen, the hepatocyte will interact with a large number of lymphocytes, both by direct cell to cell contact and by indirect means through the secretion of cytokines and chemokines. These interactions may lead on the one hand to the death of infected hepatocytes or suppression of viral replication and on the other hand to the death of T lymphocytes or down regulation of their function. We suggest that activation of lymphocytes in lymphoid organs leads to generation of effector T cells (positive loop), while at the same time presentation of antigen in the liver either on hepatocytes or other specialised antigen presenting cells depresses these responses (negative loop). This model helps to explain both the specific phenotype and low frequencies of HCV specific CTL in chronic infection, through early elimination of cells before expansion and maturation can occur. The outcome of HCV infection is likely to result from the early balance between these two simultaneous loops.     

Suppression of responses to cryptococcal antigen in murine cryptococcosis

Subpopulations of spleen cells responsible for responsiveness and unresponsiveness to cryptococcal antigen in vitro were identified. Lymphocytes which responded in lymphocyte transformation (LT) assays were nylon wool nonadherent and theta antigen positive. These lymphocytes required the presence of an accessory cell which could be supplied by normal peritoneal exudate cells. Spleen cells taken from mice which had been infected for 3 to 15 days were tested to determine their ability to respond to cryptococcal antigen in LT assays. A minimal response was detected at the ninth day of infection. The response of infected spleen cells was attributed to a nonadherent lymphocyte. Nonadherent spleen cells of infected animals had enhanced responses after removal of adherent cells and addition of normal peritoneal exudate cells. Suppressor cells were detected in the spleens of infected mice by the 12th day of infection and thereafter. A nonadherent suppressor cell was identified, but indirect evidence suggested that an adherent cell could also be present in infected spleens.     

大鼠细小病毒H-1株培养方法的建立

目的建立用大鼠胶质瘤细胞系（Rat glial cell line C6）替代大鼠原代胚细胞（primary rat embryocells,RE）培养大鼠细小病毒（Toolan virus,H-1）的方法。方法 将0.8 mL H-1病毒接种C6细胞（75T培养瓶,细胞接种量为2×105/mL,培养过夜）,待细胞病变CPE达＋＋～＋＋＋时,用免疫荧光（FITC）鉴定所培养病毒的抗原,用血球凝集试验（HA）测定培养物上清效价,用DNA测序鉴定所培养的病毒,用96孔板培养法测定H-1病毒的TCID50。结果H-1在接种到C6细胞的第3～4天,细胞发生明显的病变,CPE可达＋＋＋＋,FITC鉴定呈H-1抗原阳性,病毒的培养上清中HA效价为1∶320。测序结果表明：该病毒序列与NCBI中H-1序列同源性达99%,确定为H-1病毒。收获的H-1的TCID50为103.2/0.1 mL。结论用大鼠胶质瘤细胞系（C6）可以替代大鼠原代胚细胞（RE）进行大鼠细小病毒的培养。     

丙型肝炎病毒分片段抗体检测蛋白质芯片的制备及临床评价

为了制备丙型肝炎病毒分片段抗体检测蛋白质芯片,并对其临床应用价值进行评价,将基因工程表达的丙型肝炎病毒分片段抗原,点至经特殊处理的玻片上,制成蛋白质芯片.收集来自三家临床单位用于临床验证的905份血清标本.分别用丙肝病毒分片段抗体检测蛋白质芯片、ELISA丙肝病毒抗体检测试剂进行检测.部分样本同时采用进口RIBA抗体检测试剂进行了检测,分别比较蛋白质芯片法与ELISA法以及RIBA试剂的符合率.结果表明：a.905份血清标本,ELISA法检出阳性294份,阴性611份.阳性标本用蛋白质芯片法检测,融合抗原292份显示阳性结果、2份阴性结果,根据蛋白质芯片的核心抗原,以及NS3, NS4,NS5分片段抗原综合判断确定阳性样本288份阳性,阴性样本2份,4份样本结果不确定.ELISA法检出的611份阴性标本用两种蛋白质芯片法检测,检出阴性均为611份.两种蛋白质芯片法与ELISA法的阳性符合率分别为99.3%和98.9%,与ELISA法的阴性符合率均为100%.用RIBA 试剂检测6份ELISA法为阳性,蛋白质芯片法为非阳性的样本,结果均为非阳性.b.290份经 RIBA试剂确认的阳性标本104份,单片段阳性标本66份,阴性标本120份,用蛋白质芯片法检测,检出阳性标本103份,单片段阳性标本61份,阴性标本126份,二者具有很高的符合率（P＞0.01）.丙型肝炎病毒分片段抗体检测蛋白质芯片,检测灵敏度和特异性高于ELISA法,对血清样本的确认程度与进口的RIBA试剂高度一致,具有操作简便,费用低廉的特点,是一种新型、高效的体外诊断试剂.     

Alkaline phosphatase staining of pig and sheep epiblast cells in culture

To define better the characteristics of pig and sheep epiblast cells in culture, the cells were tested for the presence of alkaline phosphatase (AP), a biochemical marker characteristic of mouse embryonic stem cells. Pig and sheep epiblast cells were positive for AP staining both at isolation from the blastocyst and after primary in vitro culture. The innermost portion of the attendant endoderm surrounding the epiblast was also positive for AP staining during primary culture. AP staining was lost upon differentiation or senescence of the epiblast cells. Also, all differentiated epiblast-derived cell cultures were negative for AP staining, with the exception of neuron-like cultures. Epiblast-like cells were cultured from day 10 (pig) and day 13 (sheep) embryonic discs, and these cells were also AP positive until they differentiated. Trophectoderm-endoderm-like cells from embryonic discs were AP negative or weakly positive. AP is a convenient marker for undifferentiated pig and sheep epiblast cells in culture when used in conjunction with cell morphology analysis. © 1993 Wiley-Liss, Inc.